Wellborn Gayle Furgurson
SEC Form 4 insider trading activity
Wellborn Gayle Furgurson has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 29, 2026.
On the most recent filing, Wellborn Gayle Furgurson is listed as Director at HEALTHEQUITY, INC. Inside the rolling window, Wellborn Gayle Furgurson reported no open-market purchases and 2 open-market sales totaling $645K in HQY. The largest disclosed transaction in the window is a sale of 4,339 HQY shares on Dec 12, 2025, worth $425K.
Companies traded
Other insiders at HQY
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$645K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Wellborn Gayle Furgurson made?
Wellborn Gayle Furgurson has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Wellborn Gayle Furgurson trade?
Wellborn Gayle Furgurson has filed SEC Form 4 disclosures for 1 company, including HQY.
When was Wellborn Gayle Furgurson's most recent SEC Form 4 filing?
Wellborn Gayle Furgurson's most recent SEC Form 4 filing on Tracefour is dated Jun 29, 2026.
What is Wellborn Gayle Furgurson's total buy and sell value in the current window?
Inside the rolling retention window, Wellborn Gayle Furgurson bought $0 and sold $645K based on SEC Form 4 filings.
What was Wellborn Gayle Furgurson's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,339 HQY shares on 2025-12-12, worth $425K, per SEC Form 4 filings.